REFERENCES
- Rojkind M, Giambrone M-A, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979; 78: 710–9.
- Bentsen KD, Henriksen JH, Bendtsen F, Horsley-Petersen K, Lorenzen I. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Hepatology 1990; 6: 957 —63.
- Hartmann DJ, Trinchet J-C, Richard-Blum S, Beugrand M, Callard P, Ville G. Radioimmu-noassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseases. Clin Chem 1990; 36: 421–6.
- Trinchet J-C, Hartmann DJ, Paterson D, Lariif M, Callard P, Ville G, Beugrand M. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. J Heptal 1991; 12: 139–44.
- Rasman AS, Lieber CS. Diagnostic utility of laboratory test in alcoholic liver disease. Clin Chem 1994; 40: 1641–51.
- Rasmussen HB, Teisner B, Andersen JA, Yde-Andersen E, Leigh IM. Fetal antigen 2 (FA2) in relation to wound healing and fibroblast prolifera-tion. Br J Dermatol 1992; 126: 148–53.
- Rasmussen HB, Teisner B, Bangsgaard-Pedersen F, Yde-Andersen E, Kassem M. Quantification of fetal antigen 2 (FA2) in supernatants of cultured osteoblasts, normal human serum and serum from patients with chronic renal failure. Nephrol Dial Transpl 1992; 7: 902–7.
- Melkko J, Hellevik T, Ristelli L, Ristelli J, Smedsrod B. Clearence of NH2-terminal pro-peptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994; 179: 405–12.
- Henriksen JH, Ring-Larsen E, Kanstrup I-L, Christensen NJ. Splanchnic and renal elimination and release of catecholamines in cirrhosis: evi-dence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 1984; 25: 1034–43.
- Henriksen JH, Winkler K. Hepatic blood flow determination: a comparison of 99m-Tc-diethyl-IDA and indocyanine green as hepatic flow indicators in man. J Hepatol 1987; 4: 60–70.
- Tygstrup N. Determination of the hepatic galac-tose elimination capacity after a single intravenous injection and the influence of uneven distribution. Acta Physiol Scand 1963; 58: 162–9.
- Orum 0, Hansen M, Jensen CH, Sorensen HA, Jensen LB, Horslev-Petersen K, Teisner B. Pro-collagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval and hypovitamin-osis D induced hyperparathyroidism. Bone 1996; 19: 157–63.
- Teisner B, Rasmusen HB, Hojrup P, Yde-Andersen E, Skjodt K. Fetal antigen 2: An amniotic protein identified as the aminopropeptide of the a-1 chain of human procollagen type 1. APMIS 1992; 100: 1106–14.
- Rasmussen HB. Fetal antigen 2 (FA2): The aminopropeptide of the a-1 chain of human type I procollagen. A study on skin, tumor biology and bone metabolism. APMIS 1993; 101: 5–28.
- Orrego H, Medline A, Blendis LM, Rankin JG, Kreaden DA. Collagenisation of the Disse space in alcoholic liver disease. Gut 1979; 20: 673–9.
- Horn T, Junge J, Christoffersen P. Early alcoholic changes of the Disse space in the acinar zone 3. Liver 1985; 5: 301–10.
- Ring-Larsen H. Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver function. Scand J Clin Lab Invest 1977; 37: 635–42.
- Moller S, Hansen M, Hillingso J, Jensen J, Henriksen J. Elevated carboxy-terminal-linked telopeptide of type 1 collagen (ICTP) in alcoholic cirrhosis: relations to liver and kidney function and bone metabolism. GUT 1999; 3: 417–23.